105 related articles for article (PubMed ID: 15116156)
1. Effects of coronary artery by-pass grafting on haemostatic factors.
Lisowski P; Małyszko J; Jackowsk R; Myśliwiec M; Lisowska A; Łapiński T; Pawlak K; Hirnle T
Kardiol Pol; 2004 Feb; 60(2):112-22. PubMed ID: 15116156
[TBL] [Abstract][Full Text] [Related]
2. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
[TBL] [Abstract][Full Text] [Related]
3. [Does extracorporeal circulation during coronary artery bypass grafting damage vascular endothelium?].
Kotschy M; Zekanowska E; Rość D; Missima M; Ogorzeja W; Kotschy D
Pol Merkur Lekarski; 2003 Aug; 15(86):135-9. PubMed ID: 14648977
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of markers of thrombin generation in the acute and chronic phases of non cardioembolic ischemic stroke.
Soncini M; Gasparini P; Lorena M; Motta A; Cimminiello C
Minerva Cardioangiol; 2000 Nov; 48(11):349-56. PubMed ID: 11214426
[TBL] [Abstract][Full Text] [Related]
5. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
[TBL] [Abstract][Full Text] [Related]
6. Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery.
Parolari A; Mussoni L; Frigerio M; Naliato M; Alamanni F; Galanti A; Fiore G; Veglia F; Tremoli E; Biglioli P; Camera M
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):303-8. PubMed ID: 16077391
[TBL] [Abstract][Full Text] [Related]
7. Serum adiponectin and markers of endothelial dysfunction in stable angina pectoris patients undergoing coronary artery bypass grafting (CABG).
Lisowska A; Lisowski P; Knapp M; Tycinska A; Sawicki R; Malyszko J; Hirnle T; Musial WJ
Adv Med Sci; 2014 Sep; 59(2):245-9. PubMed ID: 25108276
[TBL] [Abstract][Full Text] [Related]
8. Intermittent pneumatic compression in stable claudicants: effect on hemostasis and endothelial function.
Sutkowska E; Wozniewski M; Gamian A; Gosk-Bierska I; Alexewicz P; Sutkowski K; Wysokinski WE
Int Angiol; 2009 Oct; 28(5):373-9. PubMed ID: 19935591
[TBL] [Abstract][Full Text] [Related]
9. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease.
Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):171-6. PubMed ID: 15649725
[TBL] [Abstract][Full Text] [Related]
10. Levels of F(1+2) prothrombin fragments and thrombin - antithrombin III (TAT) complexes in patients with dermatitis herpetiformis.
Wankiewicz A; Iwan-Zietek I; Gwieździński Z; Kotschy M
Med Sci Monit; 2002 Aug; 8(8):BR324-7. PubMed ID: 12165736
[TBL] [Abstract][Full Text] [Related]
11. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
[TBL] [Abstract][Full Text] [Related]
12. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
Lee KW; Blann AD; Lip GY
Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
[TBL] [Abstract][Full Text] [Related]
13. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
[TBL] [Abstract][Full Text] [Related]
14. Thrombophilic variables do not increase the generation or procoagulant activity of thrombin during cardiopulmonary bypass.
Raivio P; Petäjä J; Kuitunen A; Lassila R
Ann Thorac Surg; 2008 Feb; 85(2):536-42. PubMed ID: 18222259
[TBL] [Abstract][Full Text] [Related]
15. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
Lee KW; Blann AD; Lip GY
Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-antithrombin complexes and prothrombin fragment 1+2 in aorto-coronary bypass surgery: relation to graft occlusion.
Rifón J; Páramo JA; Prósper F; Collados MT; Sarrá J; Rocha E
Hematol Pathol; 1994; 8(1-2):35-42. PubMed ID: 8034556
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of von Willebrand-factor as a marker of endothelial dysfunction in atherosclerotic patients].
Horváth B; Hegedüs D; Szapáry L; Márton Z; Alexy T; Koltai K; Gyevnár Z; Juricskay I; Tóth K; Késmárky G
Orv Hetil; 2003 Dec; 144(50):2471-6. PubMed ID: 15067986
[TBL] [Abstract][Full Text] [Related]
18. Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis.
Kienast J; Thompson SG; Raskino C; Pelzer H; Fechtrup C; Ostermann H; van de Loo J
Thromb Haemost; 1993 Oct; 70(4):550-3. PubMed ID: 8115978
[TBL] [Abstract][Full Text] [Related]
19. Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system.
Wippermann J; Albes JM; Hartrumpf M; Kaluza M; Vollandt R; Bruhin R; Wahlers T
Eur J Cardiothorac Surg; 2005 Jul; 28(1):127-32. PubMed ID: 15939621
[TBL] [Abstract][Full Text] [Related]
20. [Concentration of prothrombin fragments 1+2 (F1+2) and thrombin-antithrombin III complexes (TAT)in patients with primary non-small cell lung cancer, before and after resection].
Kostecka IA; Haponowicz B; Sienkiewicz P; Wierzbicka M
Przegl Lek; 2000; 57(9):451-4. PubMed ID: 11199863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
